GLENMARK LIFE SCIENCES
Back to Cashflow Statement
|
GLENMARK LIFE SCIENCES Last 5 Year Cash Flow from Operating Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹414 Cr | ₹306 Cr | ₹598 Cr | ₹388 Cr | ₹195 Cr |
What is the latest Cash Flow from Operating Activities ratio of GLENMARK LIFE SCIENCES ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹414 Cr |
Mar2023 | ₹306 Cr |
Mar2022 | ₹598 Cr |
Mar2021 | ₹388 Cr |
Mar2020 | ₹195 Cr |
How is Cash Flow from Operating Activities of GLENMARK LIFE SCIENCES Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹414 Cr | 35.13 | |
Mar2023 | ₹306 Cr | -48.79 | |
Mar2022 | ₹598 Cr | 53.97 | |
Mar2021 | ₹388 Cr | 99.03 | |
Mar2020 | ₹195 Cr | - |
Compare Cash Flow from Operating Activities of peers of GLENMARK LIFE SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK LIFE SCIENCES | ₹13,309.0 Cr | -0.6% | 7% | 70.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹427,478.0 Cr | -1.3% | -4.8% | 45% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,822.0 Cr | 0.5% | 6.4% | 58.2% | Stock Analytics | |
CIPLA | ₹123,920.0 Cr | 2.1% | 3.8% | 24.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,322.0 Cr | -0.6% | -5.7% | 5.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,217.3 Cr | 0.1% | -3.6% | 48.2% | Stock Analytics |
GLENMARK LIFE SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK LIFE SCIENCES | -0.6% |
7% |
70.9% |
SENSEX | 0.9% |
-0.3% |
20.9% |
You may also like the below Video Courses